Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralymphatic Specific Immunotherapy for Grass-pollen Allergy
NCT01166269Phase 3Completed
- Sponsor
- Rigshospitalet
- Start
- Jul 2010
- Primary completion
- Nov 2012
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of phleum pratense allergen extract in allergic rhinitis due to grass pollen, sponsored by Rigshospitalet. Started Jul 2010; status: completed.
02
Drugs
phleum pratense allergen extract
03
Conditions
allergic rhinitis due to grass pollen
Beyond the preview
Go deeper on NCT01166269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01166269.